Logo image of OCDX

ORTHO CLINICAL DIAGNOSTICS H (OCDX) Stock Analyst Ratings

NASDAQ:OCDX - Nasdaq - GB00BMDNH979 - Common Stock

17.63  +0.08 (+0.46%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to OCDX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 21.74. This target is 23.3% above the current price.
OCDX was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about OCDX.
In the previous month the buy percentage consensus was at a similar level.
OCDX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

OCDX Historical Analyst RatingsOCDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15

Price Target & Forecast

Price Low Median Mean High 17.6317.1720.9121.7428.35 - -2.61% 18.60% 23.30% 60.81%

Related screens

OCDX Current Analyst RatingOCDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2022-05-06 Morgan Stanley Maintains Equal-Weight
2022-02-17 Evercore ISI Group Upgrade In-Line -> Outperform
2021-12-27 Barclays Downgrade Overweight -> Equal-Weight
2021-12-27 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-12-23 Evercore ISI Group Downgrade Outperform -> In-Line
2021-08-05 HC Wainwright & Co. Maintains Buy
2021-07-13 Barclays Maintains Overweight
2021-05-06 Credit Suisse Maintains Outperform
2021-05-06 Morgan Stanley Maintains Overweight
2021-03-03 Barclays Initiate Overweight
2021-02-22 UBS Initiate Buy
2021-02-22 Credit Suisse Initiate Outperform
2021-02-22 Morgan Stanley Initiate Overweight
2021-02-22 Piper Sandler Initiate Overweight
2021-02-22 HC Wainwright & Co. Initiate Buy